Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Antiviral therapy - 1 Jan 2006

Vergne Laurence, Diagbouga Serge, Kouanfack Charles, Aghokeng Avelin, Butel Christelle, Laurent Christian, Noumssi Nathalie, Tardy Michêle, Sawadogo Adrien, Drabo Joseph, Hien Hervé, Zekeng Léopold, Delaporte Eric, Peeters Martine

Abstract excerpt

We analysed whether mutations associated with resistance to antiretroviral (ARV) drugs circulate among treatment-naive HIV-1-infected individuals at a period when these drugs started to become more widely available in Africa. Overall, major resistance mutations in the pol gene, as defined by the International AIDS Society Resistance Testing-USA panel, were observed in 16 treatment-naive individuals. Eight of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Burkina Faso

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cameroon

Share to Drug Resistance, Multiple, Viral

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to National Health Programs

Share to RNA-Directed DNA Polymerase

Source

Identifiers

PMID: 16964825

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.PMID 16964825Read ↗

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.Semantic proximity Read ↗

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.Semantic proximity Read ↗

Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso.Semantic proximity Read ↗

In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.Semantic proximity Read ↗

Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.Semantic proximity Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

Update on HIV-1 acquired and transmitted drug resistance in Africa.Semantic proximity Read ↗

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.Semantic proximity Read ↗

Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis.Semantic proximity Read ↗

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesSemantic proximity Read ↗

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.Semantic proximity Read ↗

Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.